Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.50 -0.21%
Revenue Growth %: +21.2%
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +21.2%
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $1.13, $0.14 better than the analyst estimate of $0.99. Revenue for the quarter came in at $572.1 million versus the consensus estimate of $508.62 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
- Sirius XM (SIRI) call put ratio 11 calls to 1 put with a focus on 1600 contracts of June 40 calls
- Costco (COST) call put ratio 1.5 calls to 1 put into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
